Evaluates the molecular response up to 5 log reduction which is undetectable BCR-ABL1.
The reporting is based on European Treatment and Outcome Study (EUTOS) guidelines and European Leukemia Net (ELN) recommendations
The quantitation standards provided are with known copy numbers and are calibrated against WHO 1st International Genetic Reference Panel for the quantitation of BCR-ABL1 translocation (09/138) for assigning IS values to a measured level of BCR ABL/ABL %.
The minor BCR-ABL1 and micro BCR-ABL1 are reported in NCN%.
The kit supports reverse transcription. No additional cDNA steps are required.
High-Quality Mastermix shows Increased Inhibitor Tolerance, Thermostability, and Reproducibility.